EGFR and adenocarcinoma: To further understand the role of CEA heterogeneity in lung tumors, we divided adenocarcinomas with EGFR mutations into four groups based on CEAIn and CEAPd levels and discovered that patients displaying high CEAIn but low CEAPd levels tended to develop new metastasis.